Quantitative analysis of p16 methylation in Barrett's carcinogenesis
Authors:
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 47, 151554
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (PI 11/02089)
- Gobierno de Aragón (B-01)
This publication has 24 references indexed in Scilit:
- Incidence of esophageal adenocarcinoma in Barrett's esophagus with low-grade dysplasia: a systematic review and meta-analysisGastrointestinal Endoscopy, 2014
- Trends in esophageal adenocarcinoma incidence and mortalityCancer, 2012
- Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencingBritish Journal of Cancer, 2006
- Methylation of APC, TIMP3, and TERT: a new predictive marker to distinguish Barrett's oesophagus patients at risk for malignant transformationThe Journal of Pathology, 2005
- INK4a-ARF alterations in Barrett?s epithelium, intraepithelial neoplasia and Barrett?s adenocarcinomaVirchows Archiv, 2004
- Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tractInternational Journal of Cancer, 2004
- Hypermethylation of a Small CpGuanine-Rich Region Correlates with Loss of Activator Protein-2α Expression during Progression of Breast CancerCancer Research, 2004
- Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmationHuman Pathology, 2001
- Is there publication bias in the reporting of cancer risk in Barrett's esophagus?Gastroenterology, 2000
- Long-term follow-up of Barrett's high-grade dysplasiaAmerican Journal of Gastroenterology, 2000